Status:
UNKNOWN
Brain, Behavior and Endocrine Effects of Transcutaneous Vagus Nerve Stimulation
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
All Genders
18-28 years
Phase:
NA
Brief Summary
The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) promotes oxytocin release and the potential biomarkers of tVNS based on eye-tracking data
Detailed Description
A randomized, single-blinded, sham-controlled, within-subject, crossover design will be employed in this study. In a randomized order, a total of 54 healthy subjects will receive transcutaneous vagus ...
Eligibility Criteria
Inclusion
- Healthy subjects without past or current psychiatric or neurological disorders
Exclusion
- history of head injury;
- pregnant, menstruating, taking oral contraceptives;
- medical or psychiatric illness.
Key Trial Info
Start Date :
March 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04890457
Start Date
March 5 2021
End Date
December 30 2021
Last Update
June 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Electronic Science and Technology of China
Chengdu, Sichuan, China, 611731